Carisma Therapeutics to get $80M in cash and investment through new deal with Moderna

January 10, 2022

Philadelphia cell therapy developer Carisma Therapeutics has entered into a research collaboration with Moderna that includes Carisma receiving an upfront payment of $45 million.